NUTX - Nutex Health, Inc. Stock Price, Fair Value and News

0.72USD-0.02 (-2.70%)Delayed

Market Summary

USD0.72-0.02

Delayed

-2.70%

NUTX Stock Price

View Fullscreen

NUTX RSI Chart

NUTX Valuation

Market Cap

35.8M

Price/Earnings (Trailing)

-0.86

Price/Sales (Trailing)

0.14

EV/EBITDA

-3.45

Price/Free Cashflow

NUTX Price/Sales (Trailing)

NUTX Profitability

Operating Margin

93.22%

EBT Margin

-15.77%

Return on Equity

-52.23%

Return on Assets

-10.34%

Free Cashflow Yield

9.09%

NUTX Fundamentals

NUTX Revenue

Revenue (TTM)

258.8M

Rev. Growth (Yr)

19.75%

Rev. Growth (Qtr)

-3.18%

NUTX Earnings

Earnings (TTM)

-41.8M

Earnings Growth (Yr)

94.74%

Earnings Growth (Qtr)

98.85%

Breaking Down NUTX Revenue

Last 7 days

14.3%

Last 30 days

9.1%

Last 90 days

-60.7%

Trailing 12 Months

-90.4%

How does NUTX drawdown profile look like?

NUTX Financial Health

Current Ratio

1.68

Debt/Equity

0.33

Debt/Cashflow

0.12

NUTX Investor Care

Shares Dilution (1Y)

13.59%

Diluted EPS (TTM)

-1.06

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	258.8M	0	0	0
2023	196.5M	197.4M	231.7M	247.6M
2022	323.3M	318.5M	229.0M	219.3M
2021	288.4M	302.8M	317.2M	331.5M
2020	69.5M	137.7M	205.9M	274.0M
2019	1.6M	2.0M	1.7M	1.4M
2018	359.1K	695.1K	1.0M	1.4M
2017	216.7K	152.2K	87.7K	23.2K
2016	410.2K	345.7K	281.2K	0
2015	1.1M	1.2M	1.2M	474.7K
2014	1.3M	1.2M	1.1M	1.1M
2013	1.5M	1.5M	1.4M	1.5M
2012	1.9M	1.8M	1.8M	1.6M
2011	1.1M	1.3M	1.6M	1.8M
2010	0	0	0	874.8K

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Nutex Health, Inc.

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 12, 2024	montgomery pamela w.	acquired	-	-	16,502	chief legal officer
Mar 12, 2024	bates jon christian	acquired	-	-	49,505	chief financial officer
Nov 20, 2023	vo thomas t.	bought	62,195	0.226	275,200	chief executive officer
Nov 17, 2023	vo thomas t.	bought	51,704	0.23	224,800	chief executive officer
Nov 15, 2023	detillio joshua	bought	34,174	0.2441	140,000	chief operating officer
Sep 22, 2023	hosseinion warren	gifted	-	-	-141,000	president
Aug 31, 2023	vo thomas t.	bought	42,651	0.28	152,326	chief executive officer
Aug 30, 2023	vo thomas t.	bought	94,843	0.31	305,947	chief executive officer
Aug 29, 2023	vo thomas t.	bought	102,823	0.3	342,744	chief executive officer
Aug 28, 2023	vo thomas t.	bought	55,715	0.28	198,983	chief executive officer

Which funds bought or sold NUTX recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	new	-	2,063	2,063	-%
May 15, 2024	Cubist Systematic Strategies, LLC	added	271,720	1,302	1,303	-%
May 15, 2024	Tower Research Capital LLC (TRC)	added	37.87	-2,724	7,568	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	sold off	-100	-23,088	-	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	648	6,852	9,145	-%
May 15, 2024	Royal Bank of Canada	reduced	-19.47	-	-	-%
May 15, 2024	GOLDMAN SACHS GROUP INC	sold off	-100	-7,092	-	-%
May 15, 2024	STATE STREET CORP	unchanged	-	-7,056	8,046	-%
May 15, 2024	MORGAN STANLEY	added	10.81	-4,834	6,968	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	reduced	-4.13	-1,045	1,069	-%

Are Funds Buying or Selling NUTX?

Are funds buying NUTX calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own NUTX

No. of Funds

Unveiling Nutex Health, Inc.'s Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Sep 26, 2023	premier macy management holdings, llc	4.99%	33,046,116	SC 13G/A
Jul 07, 2023	premier macy management holdings, llc	320%	41,494,039	SC 13G

Recent SEC filings of Nutex Health, Inc.

View All Filings

Date Filed	Form Type	Document
May 09, 2024	10-Q	Quarterly Report
May 09, 2024	8-K	Current Report
May 06, 2024	DEF 14A	DEF 14A
May 06, 2024	DEFA14A	DEFA14A
May 06, 2024	DEFA14A	DEFA14A
Apr 30, 2024	10-K/A	Annual Report
Apr 26, 2024	PRE 14A	PRE 14A
Apr 12, 2024	3	Insider Trading
Apr 11, 2024	8-K	Current Report
Apr 08, 2024	3	Insider Trading

Nutex Health, Inc. News

Latest updates

Nutex Health, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-3.2%	67,454	69,669	62,723	58,924	56,329	53,724	28,395	58,048	79,127	63,402	117,972	62,815	47,206	31,597	15,988	379	466	459	452	445	212
Cost Of Revenue	-	-	-	-	-	-	-	-	-	4,493	4,491	4,381	4,188	1,587	235	211	265	199	252	83.00	327	168
Gross Profit	-23.1%	10,157	13,213	7,066	9,647	4,848	530	-23,712	6,638	35,815	46,597	76,008	29,137	427	157,087	139	114	267	263	111	118	44.00
Costs and Expenses	1.5%	57,297	56,456	55,657	49,278	51,482	57,043	52,108	51,410	43,312	43,916	41,963	33,677	-	-	-	-	-	-	-	-	-
Operating Expenses	-77.9%	8,708	39,358	7,887	10,009	9,293	6,309	404,968	8,016	6,577	2,654	1,546	1,533	4,577	5,395	-1,636	-531	1,206	3,843	1,017	1,604	970
S&GA Expenses	-100.0%	-	8,500	7,795	9,760	7,176	6,309	6,752	4,077	6,577	-824	1,546	1,533	4,426	2,558	699	53.00	121	-1,160	707	95.00	67.00
R&D Expenses	-	-	-	-	-	-	-	-	-	74.00	77.00	72.00	60.00	77.00	54.00	74.00	314	115	197	108	282	181
EBITDA Margin	39.0%	-0.04*	-0.06*	0.02*	-2.14*	-2.16*	-1.80*	-1.51*	0.49*	0.58*	0.46*	0.83*	0.62*	0.54*	0.58*	-	-	-	-	-	-	-
Interest Expenses	-87.1%	548	4,237	4,098	4,843	3,140	2,862	3,403	4,370	1,856	2,682	1,260	1,505	11.00	6,100	18.00	249	65.00	44.00	48.00	15.00	42.00
Income Taxes	113.0%	390	-2,998	-342	-815	-910	1,805	-8,543	19,653	176	-47.82	454	482	-	-	-	-	-	-	-	-	-
Earnings Before Taxes	99.5%	-152	-30,709	-4,866	-5,082	-7,832	-8,853	-431,452	-4,344	25,002	41,108	74,948	30,160	-4,484	144,839	1,756	227	-1,004	-3,660	-857	-1,630	-968
EBT Margin	19.5%	-0.16*	-0.20*	-0.11*	-2.30*	-2.30*	-1.91*	-1.61*	0.43*	0.53*	0.43*	0.77*	0.57*	0.49*	0.53*	-	-	-	-	-	-	-
Net Income	98.8%	-364	-31,617	-5,542	-4,266	-6,921	-14,752	-412,186	-23,998	24,826	-22,457	74,494	29,678	50,879	105,109	1,756	227	-1,122	-3,660	-857	-1,630	-968
Net Income Margin	17.3%	-0.16*	-0.20*	-0.14*	-2.22*	-2.33*	-1.94*	-1.89*	0.17*	0.33*	0.40*	0.82*	0.62*	0.55*	0.39*	-	-	-	-	-	-	-
Free Cashflow	271.8%	3,051	-1,776	-3,922	-5,878	-4,838	-1,384	-13,192	1,041	35,740	42,933	20,762	81,607	-567	88,230	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.5%	404	398	480	436	430	432	432	872	83.00	395	83.00	77.00	76.00	41.00	7.00	7.00	6.00	7.00	2.00	2.00	2.00
Current Assets	10.5%	100	91.00	90.00	92.00	89.00	98.00	108	149	15.00	154	12.00	6.00	4.00	0.00	0.00	0.00	0.00	1.00	0.00	0.00	0.00
Cash Equivalents	36.4%	30.00	22.00	27.00	33.00	33.00	34.00	37.00	48.00	13.00	36.00	34.00	38.00	4.00	26.00	0.00	0.00	0.00	1.00	0.00	1.00	1.00
Inventory	-12.2%	3.00	3.00	3.00	2.00	3.00	4.00	3.00	3.00	-	3.00	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00
Net PPE	-1.0%	81.00	81.00	85.00	83.00	8.00	82.00	72.00	10.00	0.00	152	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0%	17.00	17.00	18.00	17.00	17.00	17.00	17.00	425	58.00	1.00	55.00	55.00	55.00	-	-	-	3.00	3.00	-	-	-
Liabilities	1.6%	324	319	375	328	320	311	302	70.00	136	203	9.00	10.00	10.00	1.00	2.00	4.00	4.00	5.00	1.00	1.00	1.00
Current Liabilities	2.7%	60.00	58.00	67.00	57.00	48.00	55.00	44.00	56.00	8.00	38.00	7.00	7.00	7.00	1.00	1.00	4.00	4.00	5.00	-	-	-
Long Term Debt	0.0%	26.00	26.00	19.00	25.00	25.00	23.00	25.00	16.00	-	79.00	-	-	-	-	-	-	-	-	-	-	0.00
LT Debt, Current	-13.1%	9.00	11.00	20.00	16.00	10.00	13.00	4.00	8.00	4.00	10.00	2.00	2.00	1.00	-	-	2.00	2.00	2.00	-	-	-
LT Debt, Non Current	-100.0%	-	26.00	19.00	25.00	25.00	23.00	25.00	16.00	-	79.00	-	-	-	-	-	-	-	-	-	-	-
Shareholder's Equity	30.2%	80.00	61.00	90.00	108	110	96.00	133	556	187	192	213	161	164	147	5.00	3.00	2.00	51.00	4.00	5.00	5.00
Retained Earnings	-0.1%	-409	-409	-377	-371	-368	-363	-358	58.00	-48.65	102	-27.31	-25.40	-22.66	-18.22	-11.71	-13.46	-13.69	-12.57	-13.97	-13.59	-13.02
Additional Paid-In Capital	0.5%	472	470	467	464	460	458	458	467	121	12.00	101	93.00	89.00	17.00	17.00	17.00	15.00	14.00	16.00	15.00	15.00
Shares Outstanding	1552.4%	745	45.00	45.00	44.00	43.00	43.00	43.00	43.00	-	40.00	-	40.00	3.00	-	-	-	-	-	-	-	-
Minority Interest	-3.7%	17.00	18.00	15.00	16.00	4.00	24.00	22.00	31.00	0.00	77.00	0.00	-0.09	-0.04	-	-	-	-	-	-	-	-
Float	-	-	-	-	145	-	-	-	1,034	-	-	-	86.00	-	-	-	5.00	-	-	-	2.00	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	271.8%	3,051	-1,776	1,968	12.00	1,052	4,506	-7,301	17,662	35,741	46,424	24,254	103,322	-567	88,230	-189	-495	-872	-1,490	-861	-823	-864
Share Based Compensation	-	-	-	-	-	-	54.00	81.00	-14,142	14,197	4,027	-	-3,852	3,853	-	305	1,418	849	-259	168	503	39.00
Cashflow From Investing	-184.7%	-733	866	-3,619	-3,069	-5,416	7,880	-5,890	2,265	-8,591	-11,769	-3,491	-25,603	3,888	-61,236	50.00	-	-2.66	-662	-24.81	-19.56	-41.74
Cashflow From Financing	245.3%	5,687	-3,914	-4,276	2,975	2,945	-14,751	2,213	-7,884	-27,709	-32,774	-24,555	-68,915	393	-8,445	104	391	-22.05	3,090	187	231	2,227
Buy Backs	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1.00	1.00	-	-	-144*	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

NUTX Income Statement

2024-03-31

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue:
Total revenue	$ 67,453,787	$ 56,329,417
Operating costs and expenses:
Payroll and benefits	27,003,144	25,836,673
Contract services	11,319,454	9,189,331
Medical supplies	5,321,842	4,023,882
Depreciation and amortization	4,186,202	3,993,747
Other	9,465,967	8,438,061
Total operating costs and expenses	57,296,609	51,481,694
Gross profit	10,157,178	4,847,723
Corporate and other costs:
Facilities closing costs		217,266
Stock-based compensation expense	49,167	1,900,000
General and administrative expenses	8,658,410	7,175,544
Total corporate and other costs	8,707,577	9,292,810
Operating income (loss)	1,449,601	(4,445,087)
Interest expense, net	4,444,362	3,140,089
Gain on warrant liability	(2,600,747)
Other (income) expense	(241,192)	247,455
Loss before taxes	(152,822)	(7,832,631)
Income tax expense (benefit)	389,665	(910,659)
Net loss	(542,487)	(6,921,972)
Less: net loss attributable to noncontrolling interests	(178,412)	(1,774,693)
Net loss attributable to Nutex Health Inc.	$ (364,075)	$ (5,147,279)
Loss per common share
Basic earnings (loss) per common share (in dollar per share)	$ (0.01)	$ (0.12)
Diluted earnings (loss) perc common share (in dollar per share)	$ (0.01)	$ (0.12)
Hospital division
Revenue:
Total revenue	$ 60,029,369	$ 49,288,164
Population health management division
Revenue:
Total revenue	$ 7,424,418	$ 7,041,253

NUTX Balance Sheet

2024-03-31

CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 30,006,419	$ 22,002,056
Accounts receivable	61,533,245	58,624,301
Accounts receivable - related parties	4,213,847	4,152,068
Inventories	2,975,486	3,390,584
Prepaid expenses and other current assets	1,629,346	2,679,394
Total current assets	100,358,343	90,848,403
Property and equipment, net	80,570,705	81,387,649
Operating right-of-use assets	11,580,253	11,853,082
Finance right-of-use assets	173,920,659	176,146,329
Intangible assets, net	20,102,371	20,512,636
Goodwill, net	17,066,263	17,066,263
Other assets	685,260	431,135
Total assets	404,283,854	398,245,497
Current liabilities:
Accounts payable	17,217,905	18,899,196
Accounts payable - related parties	6,856,962	6,382,197
Lines of credit	2,777,128	3,371,676
Current portion of long-term debt	9,388,455	10,808,721
Operating lease liabilities, current portion	1,586,904	1,579,987
Finance lease liabilities, current portion	4,366,696	4,315,979
Accrued expenses and other current liabilities	17,694,134	12,955,296
Total current liabilities	59,888,184	58,313,052
Long-term debt, net	26,308,017	26,314,733
Warrant liability	5,060,810
Operating lease liabilities, net	15,097,284	15,479,639
Finance lease liabilities, net	212,867,062	213,886,213
Deferred tax liabilities	5,050,347	5,145,754
Total liabilities	324,271,704	319,139,391
Commitments and contingencies
Equity:
Common stock, $0.001 par value; 950,000,000 shares authorized; 49,719,375 and 45,111,994 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	49,719	45,112
Additional paid-in capital	472,405,834	470,480,617
Accumulated deficit	(409,436,614)	(409,072,539)
Nutex Health Inc. equity	63,018,939	61,453,190
Noncontrolling interests	16,993,211	17,652,916
Total equity	80,012,150	79,106,106
Total liabilities and equity	$ 404,283,854	$ 398,245,497

About Nutex Health, Inc.

Nutex Health Inc. operates as a network of micro-hospitals. It operates through three segments: Hospital, Population Health Management, and Real Estate. The Hospital segment develops and operates a network of micro-hospitals, specialty hospitals and hospital outpatient departments which offers 24/7 care. The Population Health Management segment establishes and operates independent physician associations; and offers a cloud-based platform for healthcare organizations to provide value-based care and population health management. The Real Estate segment leases land and hospital building. It also provides healthcare and facility management services; and healthcare billing, coding, and collection services. In addition, the company offers healthcare services, including emergency room care, inpatient care, and behavioral health, as well as onsite imaging, such as CT scan, X-ray, MRI, ultrasound, etc.; certified and accredited laboratories; and onsite inpatient pharmacies. The company was founded in 2011 and is based in Houston, Texas.

CEO	Dr. Thomas T. Vo M.B.A., M.D.
WEBSITE	nutexhealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	800

Nutex Health, Inc. Frequently Asked Questions

What is the ticker symbol for Nutex Health, Inc.? What does NUTX stand for in stocks?

NUTX is the stock ticker symbol of Nutex Health, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Nutex Health, Inc. (NUTX)?

As of Fri May 17 2024, market cap of Nutex Health, Inc. is 35.8 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of NUTX stock?

You can check NUTX's fair value in chart for subscribers.

What is the fair value of NUTX stock?

You can check NUTX's fair value in chart for subscribers. The fair value of Nutex Health, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Nutex Health, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for NUTX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Nutex Health, Inc. a good stock to buy?

The fair value guage provides a quick view whether NUTX is over valued or under valued. Whether Nutex Health, Inc. is cheap or expensive depends on the assumptions which impact Nutex Health, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NUTX.

What is Nutex Health, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, NUTX's PE ratio (Price to Earnings) is -0.86 and Price to Sales (PS) ratio is 0.14. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. NUTX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Nutex Health, Inc.'s stock?

In the past 10 years, Nutex Health, Inc. has provided -0.12 (multiply by 100 for percentage) rate of return.